Delays in Initiating Post-operative Prophylactic Biologic Therapy Are Common Among Crohn’s Disease Patients Academic Article uri icon

Overview

MeSH Major

  • Crohn Disease
  • Escherichia coli
  • Gram-Positive Bacteria
  • Ileum
  • Intestinal Mucosa

abstract

  • There are a substantial number of delays in initiating post-operative prophylactic biologic therapy in high-risk patients. Identifying susceptible patients by insurance type or absence of pre-operative therapy can focus future improvement efforts. Additionally, consultation with IBD-specialized providers should be considered in peri-surgical IBD care.

publication date

  • June 7, 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1007/s10620-018-5159-4

PubMed ID

  • 29876778

Additional Document Info

start page

  • 1

end page

  • 8